Paul Herzich
Direttore Tecnico/Scientifico/R&S presso SOLID BIOSCIENCES INC.
Patrimonio netto: 49 742 $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Alexander Cumbo | M | 53 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 4 anni |
| TY Howton | M | 52 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 3 anni |
| Ilan Ganot | M | 50 | 11 anni | |
| Ian Smith | M | 58 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 4 anni |
| Jonathan Quick | M | - | 5 anni | |
| Marie Payton | F | - | 5 anni | |
| Clare Khan | M | 72 | 3 anni | |
| Georgia Keresty | M | 62 | 3 anni | |
| Annie Ganot | F | - | 11 anni | |
| Lynne Sullivan | F | 58 | 9 anni | |
| Sukumar Nagendran | M | 58 | 6 anni | |
| Adam Stone | M | 44 | 9 anni | |
| Martin Freed | M | 63 | 6 anni | |
| Matthias Hebben | M | - | 5 anni | |
| Alison Kessler | F | - | 4 anni | |
| Kevin Tan | M | 46 | 1 anni | |
| Allison Bogosian | F | - | 3 anni | |
| Jessie Hanrahan | M | 47 | 2 anni | |
| Shuli Kulak | M | - | - | |
| Gabriel Brooks | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Douglas Swirsky | M | 54 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 2 anni |
| Stephen DiPalma | M | 66 | 2 anni | |
| Richard A. Moscicki | M | 72 | 4 anni | |
| Sheila Mikhail | F | 57 |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 anni |
| Erin Brennan | M | 53 | 1 anni | |
| Jenny Marlowe | M | 47 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 1 anni |
| Raj Shah | M | 46 | 7 anni | |
| Adam Koppel | M | 54 | 2 anni | |
| Caitlin Lowie | F | - | 1 anni | |
| Sofia Ioannidou | M | 45 | 2 anni | |
| Michael Wyzga | M | 69 | 4 anni | |
| Josh Grieger | M | - |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 3 anni |
| Adi Barzel | M | - | 4 anni | |
| Shannon Stone | F | - | 2 anni | |
| L. Smith | M | 57 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 anni |
| Rhonda L. Stanley | F | 64 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 anni |
| Carl Morris | M | 54 | 8 anni | |
| Sandra E. Poole | F | 60 | 1 anni | |
| Kenneth Huttner | M | - | 1 anni | |
| Brian Stolz | M | 48 | 1 anni | |
| Dean A. Falb | M | 63 | - | |
| Emily Cox | F | - | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 42 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Paul Herzich
- Contatti personali
